Researching an investigational treatment option for Focal Onset Epilepsy

Approximately 390 people will participate in the Rise study.

The study will consist of an 8-week observation phase, followed by an 8 to 12-week double-blind treatment phase and possible 2-week follow up.

No. If you qualify and are chosen to participate, you will receive all study-related care at no cost to you. Insurance is not required and compensation for participation may be provided.

Like all Biohaven clinical studies, your participation is fully voluntary. You may leave the study at any time.

Fill out this form to See If You Qualify